Company | Booking Holdings, Inc. |
Ticker | BKNG US |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | August 4, 2026 — 4:30 PM ET |
Prepared | August 3, 2026 |
Sector ETF (Chart) | PEJ — Invesco Dynamic Leisure & Entertainment ETF |
Key Takeaway: The setup is cautiously constructive but bar-dependent — consensus has been revised down materially since the Q1 print, leaving room night growth guidance of +2–4% as the key hurdle, and any signal that the Middle East headwind is easing faster than the assumed end-of-June recovery is the single biggest upside catalyst.
Heading into Q2 2026 results, the bar for BKNG has been reset sharply lower following the April 28 Q1 print, where management guided Q2 room night growth to only +2–4% and gross bookings/revenue/EBITDA each to +4–6%, embedding an assumed ~3-point headwind from the Middle East conflict spanning the full quarter — roughly double the Q1 impact. Consensus has tracked guidance closely, with Q2 operating EPS estimates drifting from ~$2.41 post-earnings to ~$2.41 currently (essentially flat), suggesting the street has already priced in the guided deceleration and is not expecting a meaningful beat on the headline. The real swing factor is whether the Middle East impact proved better or worse than the 3-point assumption: Marriott (reported Aug 3) and Hilton (reported Jul 28) both noted Middle East RevPAR declines of ~43% and ~30% respectively but flagged the impact was better than prior expectations, and both raised full-year RevPAR guidance — a constructive read-through for BKNG's Q2 actuals and H2 recovery assumptions. Management tone at the May Barclays and JP Morgan conferences was deliberately non-committal on near-term demand, deferring to the Q1 call guidance, but the CFO's disclosure of an additional $100M in discretionary spend pullback signals a defensive posture that could provide EBITDA cushion. The stock has recovered ~11% from its post-earnings lows but remains ~10% below pre-Q1 levels, trading at ~16.7x NTM P/E — a compressed multiple that already reflects significant uncertainty; a clean beat with any improvement in H2 recovery language could re-rate the stock meaningfully, while a miss or extension of the conflict assumption would pressure the multiple further.
Key Takeaway: Consensus reflects the guided deceleration — room night growth of ~3.2% and gross bookings growth of ~5% represent a low bar relative to BKNG's recent history, and the bigger swing factor is whether EBITDA margin holds given the $100M discretionary spend pullback and FX tailwind (~2pp to reported growth rates).
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change (Est.) | Q2 2026 Guidance (Mgmt) | Consensus vs. Guidance Midpoint |
Hotel Room Nights Sold (M) | 338M | 309M | 320M | +3.6% | +2% to +4% growth (implied ~315–321M) | ~+0% vs. midpoint (~318M) |
Gross Bookings ($B) | $53.8B | $46.7B | $49.4B | +5.8% | +4% to +6% growth (implied ~$48.6–$49.5B) | ~+0% to +2% vs. midpoint |
Total Revenues ($B) | $5.53B | $6.80B | $7.19B | +5.7% | +4% to +6% growth (implied ~$7.07–$7.21B) | ~+0% to +2% vs. midpoint |
Adj. EBITDA ($B) | $1.29B | $2.42B | $2.56B | +5.7% | +4% to +6% growth (implied ~$2.51–$2.57B) | ~+1% vs. midpoint |
Adj. EPS — Diluted ($) | $1.14 | $2.22 | $2.41 | +8.6% | N/A — no explicit EPS guidance given | N/A |
Sources: Visible Alpha Consensus and Actuals Data (Hotel room nights sold, Gross bookings, Total revenues, EBITDA – Operating, EPS-Diluted – Operating). Q2 2026 guidance from Q1 2026 earnings call (April 28, 2026). FX tailwind of ~2pp embedded in reported growth rates per management guidance.
Quarter | Reported (M) | Consensus (M) | Surprise % | Result |
Q2 2024 | 287 | 285 | +0.7% | Beat |
Q3 2024 | 299 | 291 | +2.8% | Beat |
Q4 2024 | 261 | 250 | +4.3% | Beat |
Q1 2025 | 319 | 318 | +0.4% | Beat |
Q2 2025 | 309 | 305 | +1.4% | Beat |
Q3 2025 | 323 | 316 | +2.2% | Beat |
Q4 2025 | 285 | 279 | +2.1% | Beat |
Q1 2026 | 338 | 341 | -0.9% | Miss |
Quarter | Reported ($B) | Consensus ($B) | Surprise % | Result |
Q2 2024 | $41.4B | $41.7B | -0.7% | Miss |
Q3 2024 | $43.4B | $41.5B | +4.7% | Beat |
Q4 2024 | $37.1B | $34.5B | +7.5% | Beat |
Q1 2025 | $46.7B | $46.5B | +0.4% | Beat |
Q2 2025 | $46.7B | $46.2B | +1.0% | Beat |
Q3 2025 | $49.6B | $47.8B | +3.7% | Beat |
Q4 2025 | $43.0B | $42.0B | +2.5% | Beat |
Q1 2026 | $53.8B | $54.0B | -0.4% | Miss |
Pattern: BKNG has beaten room night consensus in 7 of the last 8 quarters and gross bookings in 6 of 8, with the only misses occurring in Q1 2026 when the Middle East conflict struck mid-quarter — suggesting the company's underlying execution is strong and the Q2 bar, set with a full-quarter conflict assumption, may again prove beatable if the impact was less severe than modeled. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance was formally lowered at the Q1 print (April 28) to reflect the Middle East conflict; no further formal revision has occurred since, but the CFO's May 5 Barclays disclosure of an additional $100M discretionary spend pullback is a meaningful post-earnings development that provides EBITDA cushion without changing the top-line guidance range.
Metric | Initial Guidance (Q4 2025 Earnings Call) | Revised Guidance (Q1 2026 Earnings Call, Apr 28) | Current Consensus | Note |
Q2 2026 Room Night Growth | Not explicitly guided at Q4 call | +2% to +4% | ~+3.6% (320M vs. 309M prior year) | ↓ New guidance issued Apr 28; embeds ~3pp Middle East headwind for full Q2 |
Q2 2026 Gross Bookings Growth | Not explicitly guided at Q4 call | +4% to +6% | ~+5.8% ($49.4B) | ↓ New guidance issued Apr 28; FX tailwind ~2pp embedded |
Q2 2026 Revenue Growth | Not explicitly guided at Q4 call | +4% to +6% | ~+5.7% ($7.19B) | ↓ New guidance issued Apr 28 |
Q2 2026 Adj. EBITDA Growth | Not explicitly guided at Q4 call | +4% to +6% | ~+5.7% ($2.56B) | ↓ New guidance Apr 28; $100M discretionary spend pullback disclosed May 5 (Barclays) provides additional cushion |
FY 2026 Gross Bookings Growth | Low double digits (prior expectation) | High single digits to low double digits | ~$203.9B (FY consensus) | ↓ Lowered Apr 28; assumes Middle East impact through end of June, recovery in H2 |
FY 2026 Revenue Growth | Low double digits (prior expectation) | High single digits | ~$29.3B (FY consensus) | ↓ Lowered Apr 28 |
FY 2026 Adj. EBITDA Margin Expansion | ~125 bps expansion (prior expectation) | 0 to +25 bps expansion | ~$10.9B FY EBITDA consensus | ↓ Lowered Apr 28; $100M spend pullback (May 5) may support high end of range |
FY 2026 Adj. EPS Growth | ~+20% (prior expectation) | Low to mid-teens growth | ~$10.42 (FY consensus) | ↓ Lowered Apr 28; long-term 15% EPS growth target reaffirmed |
Sources: Q1 2026 Earnings Call transcript (April 28, 2026); Barclays Americas Select Conference transcript (May 5, 2026); Visible Alpha Consensus and Actuals Data.
Key Takeaway: Estimates have tracked guidance closely since the Q1 print — the street has largely accepted management's Middle East framework without adding incremental pessimism, leaving consensus near the midpoint of guidance ranges for Q2 and at the low end of the FY range, which means any outperformance vs. the conflict assumption flows directly to upside.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (as of May 5, 2026) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 Call, Apr 28) | Current Guidance | Guidance Δ | Consensus vs. Guidance Midpoint |
Room Nights (Q2 2026) | 320M | 320M | ~0% | +2% to +4% (315–321M) | Unchanged | — | ~+0.6% above midpoint |
Gross Bookings (Q2 2026) | $49.3B | $49.4B | +0.2% | +4% to +6% ($48.6–$49.5B) | Unchanged | — | ~+1.6% above midpoint |
Total Revenue (Q2 2026) | $7.18B | $7.19B | +0.1% | +4% to +6% ($7.07–$7.21B) | Unchanged | — | ~+1.7% above midpoint |
Adj. EBITDA (Q2 2026) | $2.55B | $2.56B | +0.2% | +4% to +6% ($2.51–$2.57B) | Unchanged | — | ~+1.9% above midpoint |
Adj. EPS (Q2 2026) | $2.41 | $2.41 | ~0% | N/A (no explicit EPS guidance) | N/A | — | N/A |
Gross Bookings (FY 2026) | $204.2B | $203.9B | -0.2% | High single to low double digits | Unchanged | — | Near low end of range |
Total Revenue (FY 2026) | $29.4B | $29.3B | -0.3% | High single digits | Unchanged | — | Tracking guidance |
Adj. EPS (FY 2026) | $10.42 | $10.42 | ~0% | Low to mid-teens growth | Unchanged | — | Near low end of range |
Estimates have been remarkably stable since the Q1 print, moving less than 0.3% in any direction — the street has essentially anchored to management's guided ranges. The key risk is that the FY consensus sits near the low end of guidance, implying the market is not giving credit for H2 recovery; any positive signal on Middle East normalization could drive meaningful upward revisions to H2 and FY estimates.
Sources: Visible Alpha Consensus and Actuals Data (as-of date May 5, 2026 and current). Q1 2026 Earnings Call (April 28, 2026).
Key Takeaway: BKNG's underperformance since the Q1 print has been driven almost entirely by multiple compression (NTM EV/EBITDA contracted from ~14.8x to ~13.0x over 6 months), not estimate cuts — suggesting the stock is pricing in a risk premium for the Middle East uncertainty that could unwind quickly if Q2 results confirm the conflict impact is tracking or better than assumed.
Since the Q1 2026 earnings release on April 28, 2026, BKNG has traded from $173.38 to $192.71 (as of August 4, 2026), a gain of approximately +11.2% — but this masks significant intra-period volatility. The stock initially sold off sharply to a low near $154 in mid-May as investors digested the guidance reduction, before recovering as hotel peers (Hilton, Marriott, Hyatt) reported strong Q2 results and raised full-year RevPAR guidance in late July. Over the same period, PEJ (Invesco Dynamic Leisure & Entertainment ETF) gained approximately +10.8% and the S&P 500 (SPY) gained approximately +6.5%, indicating BKNG broadly tracked its leisure peer group but lagged on a risk-adjusted basis given its higher beta to the Middle East narrative. The stock's NTM P/E of 16.7x and EV/EBITDA of 13.0x represent a meaningful discount to its 12-month-ago multiples (23.2x P/E, 17.8x EV/EBITDA), with the compression driven by the Middle East overhang rather than fundamental deterioration. Key events marked on the chart: Q1 earnings (Apr 28), Barclays conference (May 5), JP Morgan TMC conference (May 20), Hilton Q2 earnings (Jul 28), Hyatt Q2 earnings (Jul 30), Marriott Q2 earnings (Aug 3).
Chart: BKNG vs. PEJ vs. SPY — Indexed to 100 at April 28, 2026 (Q1 Earnings Date)
Date | BKNG (Indexed) | PEJ (Indexed) | SPY (Indexed) |
Apr 28, 2026 (Base) | 100.0 | 100.0 | 100.0 |
May 13, 2026 (Trough) | 89.4 | 97.6 | 104.3 |
Jun 24, 2026 (TCOM Q1 Results) | 104.5 | 109.5 | 103.0 |
Jul 28, 2026 (HLT Q2 Earnings) | 114.9 | 112.4 | 104.1 |
Aug 4, 2026 (Current) | 111.2 | 110.8 | 106.5 |
Note: Indexed values calculated from raw close prices (BKNG base: $173.38; PEJ base: $60.34; SPY base: $711.69). Source: Stock Price Data (Yahoo Finance).
Key Takeaway: The most important post-Q1 development is the hotel peer read-through from Marriott and Hilton Q2 results (both reported in the last week), which confirm the Middle East impact was better than feared and global leisure demand remains robust — a constructive setup for BKNG's Q2 print.
Key Takeaway: All recent insider transactions are pre-planned 10b5-1 sales — no discretionary open-market selling or buying; the activity is routine and does not signal any incremental bearish or bullish conviction from insiders ahead of the print.
Name | Title | Transaction Type | Shares | Est. Value | Transaction Date | Note |
Robert J. Mylod Jr. | Director | 10b5-1 Planned Sale | 5,000 | ~$1.0M | Jul 29, 2026 | Pre-planned; sold via Annox Capital LLC (indirect). Form 144 filed Jul 29 for $1M intended sale. |
Vanessa Ames Wittman | Director | 10b5-1 Planned Sale | 1,125 | ~$216K | Jul 28, 2026 | Pre-planned (10b5-1 plan initiated Jun 2, 2025); 6% of holdings. Routine scheduled sale. |
Peter J. Millones | EVP, General Counsel | 10b5-1 Planned Sale | 62,500 | ~$9.8M (est.) | May 26, 2026 | Pre-planned; largest transaction in the period by share count but routine for an EVP-level 10b5-1 plan. |
No open-market purchases or discretionary sales were identified in the period since the Q1 earnings release. All transactions are 10b5-1 pre-planned sales, which are obligation-driven and carry no informational signal about management's near-term view on the stock. Source: SEC Form 4 Filings / Insider Transaction Data.
Key Takeaway: Hotel peers reporting Q2 2026 results in the last week of July and early August collectively signal that the Middle East headwind is tracking better than feared, global leisure demand (especially luxury and U.S.) remains robust, and Asia-Pacific is accelerating — all constructive read-throughs for BKNG's Q2 room night volumes, ADRs, and H2 recovery assumptions. The TCOM antitrust fine is a secondary positive for BKNG's competitive positioning in Asia.
Relevance: Directly addresses Q2 2026 demand environment and raises full-year guidance — highest-quality read-through for BKNG's Q2 room night and ADR performance.
Relevance: Reported one week before BKNG; provides the most timely read on Q2 demand trends and forward booking pace.
Relevance: Hyatt's luxury-skewed portfolio and strong Asia-Pacific exposure make it a particularly relevant read-through for BKNG's premium accommodation and Agoda segments.
Relevance: TCOM's Q1 2026 results (reported June 24) include Q2 2026 forward guidance — the only OTA peer to have provided a current-quarter outlook before BKNG's print. Note: TCOM's Q1 2026 results are included here because they contain forward-looking Q2 2026 guidance, which is the current reporting quarter for BKNG.
Summary Read-Through Table
Peer | Report Date | Key Q2 Signal | Middle East Commentary | BKNG Read-Through |
MAR | Aug 3, 2026 | Global RevPAR +3.4%; U.S./Canada +5% (13-quarter high); leisure +5% globally | RevPAR -43% but better than expected; full-year impact ~100 bps (improved from 100–125 bps) | Positive |
HLT | Jul 28, 2026 | System RevPAR +3.9%; U.S. +5.4%; SMB business transient +7%+; midscale recovery to +4–6% | RevPAR -30% but better than expected; ~0.5pp full-year drag; demand extended into July | Positive |
H | Jul 30, 2026 | System RevPAR +5.9% (beat); APAC ex-China +10%; Greater China +7.2%; luxury transient +7% | RevPAR -36%; ~$10M full-year fee impact; strong forward booking pace for H2 | Positive |
TCOM | Jun 24, 2026 (Q1 results + Q2 guide) | Q2 revenue growth guided +3–8% YoY; inbound travel momentum positive; macro headwinds cited | Geopolitical volatility cited as headwind; $781M antitrust fine (Jul 27) adds idiosyncratic risk | Mixed |